These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24973031)

  • 21. "I inject less as I have easier access to pipes": injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed.
    Leonard L; DeRubeis E; Pelude L; Medd E; Birkett N; Seto J
    Int J Drug Policy; 2008 Jun; 19(3):255-64. PubMed ID: 18502378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transition to injection amongst opioid users in Iran: implications for harm reduction.
    Malekinejad M; Vazirian M
    Int J Drug Policy; 2012 Jul; 23(4):333-7. PubMed ID: 21996166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
    Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
    Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence.
    Turner KM; Hutchinson S; Vickerman P; Hope V; Craine N; Palmateer N; May M; Taylor A; De Angelis D; Cameron S; Parry J; Lyons M; Goldberg D; Allen E; Hickman M
    Addiction; 2011 Nov; 106(11):1978-88. PubMed ID: 21615585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug use among the urban poor in Kolkata: behaviour and environment correlates of low HIV infection.
    Panda S; Saha U; Pahari S; Nathan M; Poddar S; Neogi D; Sarkar M; Pal NK; Mahalanabis D
    Natl Med J India; 2002; 15(3):128-34. PubMed ID: 12186324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users.
    Wood E; Kerr T; Spittal PM; Li K; Small W; Tyndall MW; Hogg RS; O'Shaughnessy MV; Schechter MT
    J Acquir Immune Defic Syndr; 2003 Jan; 32(1):2-8. PubMed ID: 12514408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
    Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
    BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Declining risk for HIV among injecting drug users in Kathmandu, Nepal: the impact of a harm-reduction programme.
    Peak A; Rana S; Maharjan SH; Jolley D; Crofts N
    AIDS; 1995 Sep; 9(9):1067-70. PubMed ID: 8527080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of harm reduction in controlling HIV among injecting drug users.
    Wodak A; McLeod L
    AIDS; 2008 Aug; 22 Suppl 2(Suppl 2):S81-92. PubMed ID: 18641473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High risk and little knowledge: overdose experiences and knowledge among young adult nonmedical prescription opioid users.
    Frank D; Mateu-Gelabert P; Guarino H; Bennett A; Wendel T; Jessell L; Teper A
    Int J Drug Policy; 2015 Jan; 26(1):84-91. PubMed ID: 25151334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment.
    Rhodes T; Mikhailova L; Sarang A; Lowndes CM; Rylkov A; Khutorskoy M; Renton A
    Soc Sci Med; 2003 Jul; 57(1):39-54. PubMed ID: 12753815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug consumption rooms in Catalonia: A comprehensive evaluation of social, health and harm reduction benefits.
    Folch C; Lorente N; Majó X; Parés-Badell O; Roca X; Brugal T; Roux P; Carrieri P; Colom J; Casabona J;
    Int J Drug Policy; 2018 Dec; 62():24-29. PubMed ID: 30352331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
    Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
    Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A high proportion of users of low-threshold facilities with needle exchange programmes in Switzerland are currently on methadone treatment: implications for new approaches in harm reduction and care.
    Gervasoni JP; Balthasar H; Huissoud T; Jeannin A; Dubois-Arber F
    Int J Drug Policy; 2012 Jan; 23(1):33-6. PubMed ID: 21705205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes.
    de la Fuente L; Bravo MJ; Toro C; Brugal MT; Barrio G; Soriano V; Vallejo F; Ballesta R;
    J Epidemiol Community Health; 2006 Jun; 60(6):537-42. PubMed ID: 16698987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is opioid substitution treatment beneficial if injecting behaviour continues?
    Gjersing L; Bretteville-Jensen AL
    Drug Alcohol Depend; 2013 Nov; 133(1):121-6. PubMed ID: 23773951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Harm reduction--from a conceptual framework to practical experience: the example of Germany.
    Michels II; Stöver H
    Subst Use Misuse; 2012; 47(8-9):910-22. PubMed ID: 22676562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
    Neaigus A; Zhao M; Gyarmathy VA; Cisek L; Friedman SR; Baxter RC
    J Urban Health; 2008 May; 85(3):309-22. PubMed ID: 18340537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infrequent opioid overdose risk reduction behaviours among young adult heroin users in cities with wide coverage of HIV prevention programmes.
    Neira-León M; Barrio G; Bravo MJ; Brugal MT; de la Fuente L; Domingo-Salvany A; Pulido J; Santos S;
    Int J Drug Policy; 2011 Jan; 22(1):16-25. PubMed ID: 20800462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.